Analysts Set Astera Labs, Inc. (NASDAQ:ALAB) Target Price at $325.25

Astera Labs, Inc. (NASDAQ:ALAB) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-three research firms that are covering the stock, MarketBeat.com reports. Nine equities research analysts have rated the stock with a hold recommendation, thirteen have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $325.25.

A number of brokerages recently weighed in on ALAB. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. Morgan Stanley lifted their target price on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Royal Bank Of Canada boosted their target price on shares of Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Citigroup reissued a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. Finally, Needham & Company LLC raised their price target on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th.

Astera Labs Stock Performance

ALAB opened at $321.61 on Thursday. The stock has a market capitalization of $55.80 billion, a P/E ratio of 159.21 and a beta of 3.84. The company’s 50-day simple moving average is $358.00 and its two-hundred day simple moving average is $240.20. Astera Labs has a 52-week low of $97.89 and a 52-week high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same quarter last year, the firm posted $0.44 EPS. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts forecast that Astera Labs will post 2.7 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This represents a 11.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $458.38, for a total value of $3,892,104.58. Following the completion of the transaction, the director directly owned 286,863 shares in the company, valued at $131,492,261.94. The trade was a 2.87% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,256,894 shares of company stock worth $362,763,135 in the last three months. 10.40% of the stock is owned by insiders.

Hedge Funds Weigh In On Astera Labs

Institutional investors and hedge funds have recently made changes to their positions in the business. Eurizon Capital SGR S.p.A. purchased a new stake in Astera Labs in the fourth quarter worth about $18,708,000. Swedbank AB raised its stake in shares of Astera Labs by 76.8% in the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after buying an additional 33,940 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new position in shares of Astera Labs during the 4th quarter valued at about $499,000. Revere Asset Management Inc purchased a new position in shares of Astera Labs during the 4th quarter valued at about $589,000. Finally, Mitsubishi UFJ Trust & Banking Corp purchased a new position in shares of Astera Labs during the 4th quarter valued at about $10,299,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.